Centessa Pharmaceuticals (CNTA) Deferred Taxes (2022 - 2026)
Centessa Pharmaceuticals (CNTA) reported Deferred Taxes of $828000.0 for Q1 2026, down 16.78% year-over-year from $995000.0 in Q1 2025, and up 255.36% on a QoQ basis from $233000.0 in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 5 years of Deferred Taxes data on file, last reported at $828000.0 in Q1 2026.
- Quarterly Deferred Taxes fell 16.78% year-over-year to $828000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 27.13% YoY) and the FY2025 annual result came in at $2.5 million, down 5.43% from the prior year.
- Deferred Taxes grew to $828000.0 in Q1 2026 per CNTA's latest filing, from $233000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $1.3 million in Q3 2024 and bottomed at -$23.5 million in Q2 2023.
- The 5-year median for Deferred Taxes is $326500.0 (2024), against an average of -$1.7 million.
- The widest annual swing landed in 2023, when Deferred Taxes sank 2040.74%; it then soared 367.11% in 2024.
- Tracing CNTA's Deferred Taxes over 5 years: stood at -$2.8 million in 2022, then surged by 94.63% to -$149000.0 in 2023, then soared by 367.11% to $398000.0 in 2024, then sank by 41.46% to $233000.0 in 2025, then jumped by 255.36% to $828000.0 in 2026.
- Per Business Quant, the three latest CNTA Deferred Taxes figures stand at $828000.0 (Q1 2026), $233000.0 (Q4 2025), and $255000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | 828,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 828,000.00 |
| Dec 31, 2025 | 233,000.00 |
| Sep 30, 2025 | 255,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 995,000.00 |
| Dec 31, 2024 | 398,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 567,000.00 |
| Mar 31, 2024 | 434,000.00 |
| Dec 31, 2023 | -149,000.00 |
| Sep 30, 2023 | -2.89 Mn |
| Jun 30, 2023 | -23.49 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -135,000.00 |